List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 30 studies with search of: "Pramlintide"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide
Condition: Type 1 Diabetes
Interventions: Drug: placebo;   Drug: pramlintide;   Drug: placebo;   Drug: pramlintide
2 Completed An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
Conditions: Type 1 Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention: Drug: pramlintide acetate
3 Recruiting Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Glargine;   Drug: Aspart;   Drug: Lispro;   Drug: Pramlintide
4 Completed A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
Condition: IDDM
Intervention: Drug: Continuous Pramlintide infusion
5 Active, not recruiting Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
Condition: Obesity
Interventions: Drug: Placebo;   Drug: Pramlintide and Metreleptin
6 Active, not recruiting Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects
Conditions: Overweight;   Obesity
Interventions: Drug: pramlintide;   Drug: metreleptin;   Drug: pramlintide;   Drug: metreleptin;   Drug: metreleptin;   Drug: placebo 1;   Drug: placebo 1;   Drug: placebo 1;   Drug: placebo 2
7 Completed A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
Condition: Obesity
Interventions: Drug: pramlintide acetate;   Drug: placebo
8 Completed A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
Conditions: Overweight;   Obesity
Interventions: Drug: pramlintide acetate;   Drug: sibutramine;   Drug: phentermine;   Drug: placebo
9 Completed A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects
Conditions: Overweight;   Obesity
Interventions: Drug: pramlintide acetate;   Drug: recombinant-methionyl human leptin;   Drug: placebo
10 Completed Continuous Subcutaneous Infusion of Pramlintide and Insulin
Condition: Type 1 Diabetes
Intervention: Drug: Pramlintide
11 Completed A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: pramlintide acetate
12 Recruiting Pramlintide in Adolescents With Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Drug: pramlintide
13 Completed A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: pramlintide acetate;   Drug: rapid acting insulin (Humalog® [insulin lispro], Novolog® [insulin aspart], or Apidra® [insulin glulisine]);   Drug: basal insulin (Lantus® [insulin glargine], or Levemir® [insulin detemir])
14 Completed Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: pramlintide acetate
15 Completed An Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects
Conditions: Overweight;   Obesity
Intervention: Drug: pramlintide acetate
16 Completed A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
Condition: Obesity
Intervention: Drug: pramlintide acetate
17 Completed Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
Conditions: Type 1 Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention: Drug: pramlintide acetate
18 Not yet recruiting Effects of Pramlintide on Endogenous Production of Very-Low-Density-Lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
Condition: Type 2 Diabetes
Interventions: Drug: Pramlintide acetate;   Drug: Placebo
19 Completed The Effect of Pramlintide on Meal Time Insulin Bolus
Condition: Type 1 Diabetes
Interventions: Drug: pramlintide;   Procedure: continuous glucose monitoring
20 Recruiting Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Diabetes;   Weight Gain
Interventions: Drug: Pramlintide;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-30)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services